Evidence map›Paper›PMID 25852160›Full record

ArticlemBio2015

Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients.

Yohei Watanabe, Yasuha Arai, Tomo Daidoji, Norihito Kawashita, Madiha S Ibrahim, Emad El-Din M El-Gendy, Hiroaki Hiramatsu, Ritsuko Kubota-Koketsu, Tatsuya Takagi, Takeomi Murata and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Yohei Watanabenabe@biken.osaka-u.ac.jp.
Yasuha AraiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Tomo DaidojiDepartment of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Norihito Kawashita
Madiha S IbrahimDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.
Emad El-Din M El-GendyDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.
Hiroaki HiramatsuHealth Scientific Hills, College of Life and Health Sciences, Chubu University, Aichi, Japan.
Ritsuko Kubota-KoketsuKanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan.
Tatsuya Takagi
Takeomi MurataDepartment of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, Shizuoka, Japan.
Kazuo TakahashiDepartment of Infectious Diseases, Osaka Prefectural Institute of Public Health, Osaka, Japan.
Yoshinobu OkunoKanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan.
Takaaki NakayaDepartment of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yasuo SuzukiHealth Scientific Hills, College of Life and Health Sciences, Chubu University, Aichi, Japan.
Kazuyoshi IkutaDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Osaka University · JPKyoto Prefectural University of Medicine · JPChubu University · JPDamanhour University · EGOsaka Prefectural Institute of Public Health · JPOsaka University of Pharmaceutical Sciences · JPShizuoka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledA change in viral hemagglutinin (HA) receptor binding specificity from α2,3- to α2,6-linked sialic acid is necessary for highly pathogenic avian influenza (AI) virus subtype H5N1 to become pandemic. However, details of the human-adaptive change in the H5N1 virus remain unknown. Our database search of H5N1 clade 2.2.1 viruses circulating in Egypt identified multiple HA mutations that had been selected in infected patients. Using reverse genetics, we found that increases in both human receptor specificity and the HA pH threshold for membrane fusion were necessary to facilitate replication of the virus variants in human airway epithelia. Furthermore, variants with enhanced replication in human cells had decreased HA stability, apparently to compensate for the changes in viral receptor specificity and membrane fusion activity. Our findings showed that H5N1 viruses could rapidly adapt to growth in the human airway microenvironment by altering their HA properties in infected patients and provided new insights into the human-adaptive mechanisms of AI viruses. IMPORTANCE: Circulation between bird and human hosts may allow H5N1 viruses to acquire amino acid changes that increase fitness for human infections. However, human-adaptive changes in H5N1 viruses have not been adequately investigated. In this study, we found that multiple HA mutations were actually selected in H5N1-infected patients and that H5N1 variants with some of these HA mutations had increased human-type receptor specificity and increased HA membrane fusion activity, both of which are advantageous for viral replication in human airway epithelia. Furthermore, HA mutants selected during viral replication in patients were likely to have less HA stability, apparently as a compensatory mechanism. These results begin to clarify the picture of the H5N1 human-adaptive mechanism.

Indexed as

Genetic VariationMutation, MissenseAdaptation, BiologicalAnimalsCells, CulturedDisease Models, AnimalEpithelial CellsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H5N1 SubtypeInfluenza, HumanMice, Inbred BALB COrthomyxoviridae InfectionsSurvival Analysishemagglutinin, avian influenza A virusHemagglutinin Glycoproteins, Influenza Virus

Identifiers

PMID25852160
PMCPMC4453573
OpenAlexW2019769551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.